AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Carl Icahn's Strategic Moves: Southwest Gas Holdings Inc. Sees a -2% Portfolio Impact
Thu 15 May 25, 11:19 PMInvesting in International Flavors (IFF)? Don't Miss Assessing Its International Revenue Trends
Tue 13 May 25, 01:16 PMInternational Flavors & Fragrances' (NYSE:IFF) Dividend Will Be $0.40
Fri 09 May 25, 06:49 PMIFF Completes Divestiture of Nitrocellulose Business
Fri 09 May 25, 12:00 PMInternational Flavors & Fragrances First Quarter 2025 Earnings: EPS Misses Expectations
Thu 08 May 25, 11:42 AMInternational Flavors & Fragrances Inc (IFF) Q1 2025 Earnings Call Highlights: Strong Start ...
Thu 08 May 25, 07:15 AMQ1 2025 International Flavors & Fragrances Inc Earnings Call
Thu 08 May 25, 04:10 AMStocks making the biggest moves midday: Alphabet, Disney, Arista Networks, Super Micro and more
Wed 07 May 25, 04:50 PMInternational Flavors Q1 Earnings Beat Estimates, Sales Dip Y/Y
Wed 07 May 25, 04:13 PMIFF posts upbeat quarterly profit on resilient demand, prior price hikes
Tue 06 May 25, 10:14 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -1625.00000M | 354.00M | 441.37M | 557.45M | 447.76M |
| Minority interest | -7.00000M | -9.00000M | 4.14M | 4.39M | 2.48M |
| Net income | -1836.00000M | 270.00M | 363.23M | 455.87M | 337.30M |
| Selling general administrative | 1768.00M | 1749.00M | 966.13M | 876.12M | 707.46M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 4151.00M | 3735.00M | 2085.87M | 2112.75M | 1682.71M |
| Reconciled depreciation | 1179.00M | 1156.00M | 325.36M | 323.33M | 173.79M |
| Ebit | 1090.00M | 585.00M | 566.48M | 665.27M | 623.03M |
| Ebitda | 2269.00M | 1839.00M | 919.61M | 1051.13M | 796.82M |
| Depreciation and amortization | 1179.00M | 1254.00M | 353.13M | 385.87M | 173.79M |
| Non operating income net other | - | 58.00M | 6.69M | 30.40M | -3.56700M |
| Operating income | 1090.00M | 585.00M | 566.48M | 665.27M | 583.88M |
| Other operating expenses | 11387.00M | 11031.00M | 4496.68M | 4442.68M | 3389.76M |
| Interest expense | 336.00M | 289.00M | 131.80M | 138.22M | 132.56M |
| Tax provision | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M |
| Interest income | 336.00M | 289.00M | 131.80M | 137.66M | 118.41M |
| Net interest income | -336.00000M | -289.00000M | -131.80200M | -138.22100M | -132.55800M |
| Extraordinary items | - | - | - | 0.00000M | -32.80000M |
| Non recurring | - | -1.00000M | 3.78M | 2.37M | -1.17700M |
| Other items | - | - | - | - | - |
| Income tax expense | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M |
| Total revenue | 12440.00M | 11656.00M | 5084.24M | 5140.08M | 3977.54M |
| Total operating expenses | 3098.00M | 3110.00M | 1498.30M | 1415.35M | 1094.92M |
| Cost of revenue | 8289.00M | 7921.00M | 2998.37M | 3027.34M | 2294.83M |
| Total other income expense net | -2715.00000M | -231.00000M | -125.11300M | -107.81800M | -7.46900M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -1836.00000M | 279.00M | 307.53M | 424.33M | 359.54M |
| Net income applicable to common shares | -1868.00000M | 270.00M | 363.23M | 455.87M | 337.30M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 35390.00M | 39678.00M | 13555.67M | 13287.41M | 12889.40M |
| Intangible assets | 9082.00M | 10506.00M | 2727.18M | 2851.93M | 3039.32M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1970.00M | 1850.00M | 341.76M | 60.76M | 277.04M |
| Total liab | 17597.00M | 18455.00M | 7135.08M | 6958.82M | 6764.22M |
| Total stockholder equity | 17734.00M | 21118.00M | 6323.03M | 6217.30M | 6043.37M |
| Deferred long term liab | - | 2518.00M | 593.37M | 641.46M | 687.25M |
| Other current liab | -542.00000M | 3001.00M | 1269.57M | 254.32M | 608.29M |
| Common stock | 35.00M | 35.00M | 16.07M | 16.07M | 16.07M |
| Capital stock | 35.00M | 35.00M | 16.07M | 16.07M | 16.07M |
| Retained earnings | 955.00M | 3641.00M | 4156.17M | 4117.80M | 3956.22M |
| Other liab | 2956.00M | 4054.00M | 1452.00M | 1153.30M | 1131.49M |
| Good will | 13355.00M | 16414.00M | 5593.25M | 5497.60M | 5378.39M |
| Other assets | 667.00M | 1383.00M | 717.26M | 315.75M | 288.67M |
| Cash | 493.00M | 715.00M | 656.84M | 606.82M | 648.52M |
| Cash and equivalents | 483.00M | 711.00M | 649.54M | 606.82M | 634.90M |
| Total current liabilities | 3738.00M | 3633.00M | 1903.73M | 1552.19M | 1128.31M |
| Current deferred revenue | 2265.00M | -1532.00000M | -555.68700M | 362.86M | - |
| Net debt | 10477.00M | 10685.00M | 3756.68M | 3815.25M | 3904.54M |
| Short term debt | 597.00M | 632.00M | 634.16M | 424.63M | 48.64M |
| Short long term debt | 597.00M | 632.00M | 634.16M | 384.96M | 48.64M |
| Short long term debt total | 10970.00M | 11400.00M | 4413.52M | 4422.07M | 4553.06M |
| Other stockholder equity | 18913.00M | 18865.00M | 2848.34M | 2800.33M | 2773.31M |
| Property plant equipment | 4861.00M | 4368.00M | 1458.18M | 1386.92M | 1241.15M |
| Total current assets | 7432.00M | 6987.00M | 3059.80M | 2942.54M | 2941.86M |
| Long term investments | 10.00M | 86.00M | - | - | 31.47M |
| Net tangible assets | -4753.00000M | -5822.00000M | -1911.72200M | -2033.18400M | -2302.95300M |
| Short term investments | - | - | - | - | - |
| Net receivables | 1818.00M | 1906.00M | 929.34M | 1024.01M | 937.76M |
| Long term debt | 10373.00M | 10768.00M | 3779.36M | 3997.44M | 4504.42M |
| Inventory | 3151.00M | 2516.00M | 1131.86M | 1123.07M | 1078.54M |
| Accounts payable | 1418.00M | 1532.00M | 555.69M | 510.37M | 471.38M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 35.00M | 11.88M | 12.24M | 10.42M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -2169.00000M | -1423.00000M | -697.54100M | -716.89400M | -702.22700M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 35.00M | 16.07M | 16.07M | 16.07M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 3641.00M | 4156.17M | 4117.80M | 3956.22M |
| Treasury stock | - | -997.00000M | -1016.94100M | -1022.82400M | -1030.71800M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1150.00M | 1215.00M | 717.26M | 104.55M | 168.20M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 27958.00M | 32691.00M | 10495.87M | 10344.87M | 9947.54M |
| Capital lease obligations | 651.00M | 784.00M | 43.62M | 39.67M | - |
| Long term debt total | 10385.00M | 10768.00M | 3779.36M | 3997.44M | 4504.42M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | 745.00M | -18.00000M | -14.59700M | 25.90M | 7.51M |
| Change to liabilities | -57.00000M | 419.00M | 102.08M | 30.73M | 59.09M |
| Total cashflows from investing activities | 745.00M | -18.00000M | -187.46300M | -225.86600M | -5013.23500M |
| Net borrowings | -344.00000M | -606.00000M | -150.63500M | -156.28200M | 2845.52M |
| Total cash from financing activities | -1229.00000M | -1304.00000M | -511.57000M | -505.05700M | 4871.57M |
| Change to operating activities | 17.00M | -40.00000M | 88.86M | -91.37900M | -15.03300M |
| Net income | -1836.00000M | 279.00M | 367.37M | 460.27M | 339.78M |
| Change in cash | -216.00000M | 56.00M | 35.93M | -24.57700M | 280.48M |
| Begin period cash flow | 716.00M | 660.00M | 623.95M | 648.52M | 368.05M |
| End period cash flow | 500.00M | 716.00M | 659.87M | 623.95M | 648.52M |
| Total cash from operating activities | 345.00M | 1437.00M | 714.10M | 698.97M | 436.70M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 1179.00M | 1156.00M | 325.36M | 323.33M | 173.79M |
| Other cashflows from investing activities | 1251.00M | 379.00M | 18.93M | -15.78800M | -4850.65600M |
| Dividends paid | 810.00M | 667.00M | 322.58M | 313.51M | 230.22M |
| Change to inventory | -893.00000M | -363.00000M | 17.92M | -62.12900M | -117.64100M |
| Change to account receivables | -117.00000M | -169.00000M | -60.97900M | -9.46700M | -49.95800M |
| Sale purchase of stock | 0.00000M | -9.00000M | -21.56600M | 0.00000M | -15.47500M |
| Other cashflows from financing activities | 302.00M | 296.00M | 158.44M | -35.26500M | 2238.08M |
| Change to netincome | 2139.00M | 164.00M | -52.36300M | -46.14400M | 51.50M |
| Capital expenditures | 506.00M | 397.00M | 191.79M | 242.05M | 173.42M |
| Change receivables | - | -169.00000M | -60.97900M | 59.55M | -49.95800M |
| Cash flows other operating | - | 235.00M | 14.71M | -66.65000M | -18.98400M |
| Exchange rate changes | - | -59.00000M | 20.86M | 7.38M | -14.56700M |
| Cash and cash equivalents changes | - | 56.00M | 35.93M | -24.57700M | 280.48M |
| Change in working capital | -1073.00000M | -153.00000M | 73.73M | -38.48900M | -128.60300M |
| Stock based compensation | 49.00M | 54.00M | 35.80M | 34.48M | 29.40M |
| Other non cash items | 2320.00M | 337.00M | -20.44300M | -21.34700M | 2.93M |
| Free cash flow | -161.00000M | 1040.00M | 522.30M | 456.92M | 263.28M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IFF International Flavors & Fragrances Inc |
-0.31 0.42% | 72.85 | 1326.67 | 19.12 | 1.75 | 1.20 | 2.64 | 18.12 |
| LIN Linde plc Ordinary Shares |
-5.68 1.17% | 477.94 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUF L'Air Liquide S.A |
- -% | 191.86 | 29.39 | 24.69 | 3.41 | 3.97 | 3.87 | 15.91 |
| AIQUY Air Liquide SA ADR |
-0.44 1.12% | 38.71 | 30.34 | 23.04 | 3.63 | 3.77 | 3.88 | 15.62 |
| SHW Sherwin-Williams Co |
-3.07 0.92% | 330.33 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds; savory products that includes soups, sauces, meat, fish, poultry, snacks, etc.; beverages, such as juice drinks, carbonated or flavored beverages, spirits, etc.; sweets that includes bakery products, candy, cereal, chewing gum, etc.; and dairy products, such as yogurt, ice cream, cheese, etc. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered
521 West 57th Street, New York, NY, United States, 10019-2960
| Name | Title | Year Born |
|---|---|---|
| Mr. Glenn Robert Richter | Exec. VP & CFO | 1962 |
| Mr. Nicolas Mirzayantz | Pres of Nourish | 1963 |
| Mr. Franklin K. Clyburn Jr. | CEO & Director | 1965 |
| Mr. Ralf Finzel | Exec. VP & Global Operations Officer | NA |
| Ms. Beril Yildiz | Sr. VP & Chief Accounting Officer | 1978 |
| Mr. Vic Verma | Exec. VP & Chief Information Officer | 1969 |
| Mr. Michael DeVeau | Sr. VP and Chief Investor Relations & Communications Officer | 1981 |
| Dr. Jennifer Amy Johnson Ph.D. | Exec. VP & Gen. Counsel | 1975 |
| Ms. Deborah Borg | Chief HR and Diversity, Equity & Inclusion Officer | 1977 |
| Dr. Gregory Yep | Exec. VP and Chief R&D, Global Integrated Solutions & Sustainability Officer | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...